Laura Fenton
Concepts (353)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 22 | 2024 | 3722 | 1.160 |
Why?
| | Entorhinal Cortex | 1 | 2024 | 14 | 0.910 |
Why?
| | Brain Stem Neoplasms | 5 | 2015 | 83 | 0.800 |
Why?
| | Tomography, X-Ray Computed | 11 | 2014 | 2681 | 0.710 |
Why?
| | Scrotum | 2 | 2016 | 27 | 0.690 |
Why?
| | Neuroimaging | 1 | 2022 | 291 | 0.650 |
Why?
| | Brain | 6 | 2022 | 2831 | 0.580 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 386 | 0.550 |
Why?
| | Ganglioglioma | 2 | 2015 | 35 | 0.550 |
Why?
| | Wounds, Nonpenetrating | 3 | 2016 | 275 | 0.540 |
Why?
| | Esophagus | 3 | 2015 | 255 | 0.540 |
Why?
| | Diagnostic Techniques, Digestive System | 1 | 2015 | 12 | 0.490 |
Why?
| | Brain Diseases | 2 | 2019 | 141 | 0.480 |
Why?
| | Eosinophilic Esophagitis | 2 | 2020 | 325 | 0.480 |
Why?
| | Esophageal Stenosis | 1 | 2015 | 54 | 0.470 |
Why?
| | Infratentorial Neoplasms | 1 | 2014 | 63 | 0.420 |
Why?
| | Osteitis | 1 | 2013 | 2 | 0.410 |
Why?
| | Eosinophils | 1 | 2015 | 331 | 0.400 |
Why?
| | Child | 34 | 2024 | 22037 | 0.400 |
Why?
| | Ultrasonography | 3 | 2016 | 750 | 0.400 |
Why?
| | Positron-Emission Tomography | 2 | 2019 | 299 | 0.390 |
Why?
| | Prosthesis-Related Infections | 1 | 2013 | 80 | 0.380 |
Why?
| | Child, Preschool | 24 | 2019 | 11097 | 0.380 |
Why?
| | Glioma | 2 | 2009 | 397 | 0.380 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2014 | 227 | 0.370 |
Why?
| | Urea Cycle Disorders, Inborn | 1 | 2011 | 23 | 0.370 |
Why?
| | Gastritis | 1 | 2013 | 108 | 0.370 |
Why?
| | Enteritis | 1 | 2013 | 103 | 0.370 |
Why?
| | Radiography | 8 | 2016 | 834 | 0.350 |
Why?
| | Eosinophilia | 1 | 2013 | 218 | 0.340 |
Why?
| | Infant | 21 | 2019 | 9467 | 0.330 |
Why?
| | Male | 43 | 2024 | 67718 | 0.330 |
Why?
| | Liver Neoplasms | 3 | 2008 | 786 | 0.330 |
Why?
| | Radiation Injuries | 2 | 2019 | 147 | 0.330 |
Why?
| | Colitis | 1 | 2013 | 265 | 0.330 |
Why?
| | Spinal Fusion | 1 | 2013 | 251 | 0.320 |
Why?
| | Diagnosis, Differential | 9 | 2024 | 1486 | 0.320 |
Why?
| | Female | 46 | 2024 | 73162 | 0.310 |
Why?
| | Nervous System Diseases | 1 | 2011 | 265 | 0.300 |
Why?
| | Humans | 61 | 2024 | 137514 | 0.300 |
Why?
| | Pamphlets | 1 | 2007 | 23 | 0.280 |
Why?
| | Adolescent | 25 | 2024 | 21555 | 0.270 |
Why?
| | Sensitivity and Specificity | 4 | 2013 | 1950 | 0.260 |
Why?
| | Astrocytoma | 2 | 2007 | 128 | 0.260 |
Why?
| | Deglutition Disorders | 2 | 2020 | 143 | 0.260 |
Why?
| | Mutation | 3 | 2014 | 3964 | 0.260 |
Why?
| | Decision Making | 2 | 2024 | 906 | 0.250 |
Why?
| | Radiation Dosage | 1 | 2007 | 174 | 0.250 |
Why?
| | Infant, Newborn | 16 | 2019 | 6059 | 0.250 |
Why?
| | Stroke | 3 | 2022 | 1129 | 0.240 |
Why?
| | Reproducibility of Results | 6 | 2015 | 3292 | 0.240 |
Why?
| | Vertebral Artery Dissection | 2 | 2022 | 24 | 0.230 |
Why?
| | Brain Neoplasms | 3 | 2012 | 1241 | 0.230 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2008 | 360 | 0.220 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2024 | 8 | 0.220 |
Why?
| | Scurvy | 1 | 2024 | 15 | 0.220 |
Why?
| | Retrospective Studies | 14 | 2024 | 15628 | 0.210 |
Why?
| | Venous Thrombosis | 2 | 2016 | 187 | 0.210 |
Why?
| | Tomography, Emission-Computed | 1 | 2003 | 71 | 0.200 |
Why?
| | Encephalocele | 1 | 2022 | 9 | 0.200 |
Why?
| | Testicular Hydrocele | 1 | 2002 | 4 | 0.200 |
Why?
| | Cerebral Cortex | 2 | 2019 | 459 | 0.200 |
Why?
| | Brain Stem | 1 | 2003 | 104 | 0.190 |
Why?
| | Neuroblastoma | 2 | 2010 | 161 | 0.190 |
Why?
| | Teratoma | 1 | 2003 | 114 | 0.190 |
Why?
| | Rhabdoid Tumor | 1 | 2003 | 99 | 0.190 |
Why?
| | Diagnostic Errors | 1 | 2003 | 171 | 0.190 |
Why?
| | Neurofibroma, Plexiform | 1 | 2001 | 9 | 0.190 |
Why?
| | Independent Living | 1 | 2023 | 102 | 0.180 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2001 | 25 | 0.180 |
Why?
| | Abdomen | 1 | 2002 | 125 | 0.180 |
Why?
| | Mesentery | 1 | 2001 | 48 | 0.180 |
Why?
| | Aging | 2 | 2024 | 1866 | 0.180 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 97 | 0.180 |
Why?
| | Parietal Bone | 1 | 2000 | 8 | 0.180 |
Why?
| | Child Abuse | 2 | 2012 | 547 | 0.180 |
Why?
| | Connective Tissue | 1 | 2000 | 36 | 0.170 |
Why?
| | Peritoneal Neoplasms | 1 | 2001 | 94 | 0.170 |
Why?
| | Skull Fractures | 1 | 2000 | 37 | 0.170 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2000 | 21 | 0.170 |
Why?
| | Vitelline Duct | 1 | 2000 | 1 | 0.170 |
Why?
| | Educational Status | 1 | 2023 | 483 | 0.170 |
Why?
| | Intracranial Hemorrhages | 1 | 2000 | 84 | 0.170 |
Why?
| | Radiotherapy | 2 | 2019 | 201 | 0.160 |
Why?
| | Intestinal Obstruction | 1 | 2000 | 50 | 0.160 |
Why?
| | Prognosis | 5 | 2014 | 4031 | 0.160 |
Why?
| | Bevacizumab | 1 | 2019 | 137 | 0.150 |
Why?
| | Intestine, Small | 1 | 2000 | 155 | 0.150 |
Why?
| | Corpus Callosum | 1 | 2019 | 70 | 0.150 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2007 | 1332 | 0.150 |
Why?
| | Parents | 1 | 2007 | 1363 | 0.150 |
Why?
| | Hyperglycinemia, Nonketotic | 1 | 2019 | 51 | 0.150 |
Why?
| | Esophagoscopy | 2 | 2020 | 209 | 0.150 |
Why?
| | tau Proteins | 1 | 2019 | 89 | 0.140 |
Why?
| | Radiopharmaceuticals | 2 | 2013 | 178 | 0.140 |
Why?
| | Disease-Free Survival | 2 | 2014 | 690 | 0.140 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2013 | 135 | 0.140 |
Why?
| | Fatty Liver | 2 | 2012 | 242 | 0.140 |
Why?
| | Fatal Outcome | 4 | 2016 | 305 | 0.140 |
Why?
| | Angiogenesis Inhibitors | 1 | 2019 | 226 | 0.140 |
Why?
| | Magnetic Resonance Angiography | 1 | 2019 | 240 | 0.140 |
Why?
| | Smith-Magenis Syndrome | 1 | 2017 | 2 | 0.140 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2003 | 1695 | 0.140 |
Why?
| | Moyamoya Disease | 1 | 2017 | 20 | 0.140 |
Why?
| | Central Nervous System Neoplasms | 1 | 2019 | 158 | 0.130 |
Why?
| | Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2016 | 6 | 0.130 |
Why?
| | White Matter | 1 | 2019 | 148 | 0.130 |
Why?
| | Hyperammonemia | 1 | 2016 | 16 | 0.130 |
Why?
| | Bronchopulmonary Sequestration | 1 | 1996 | 8 | 0.130 |
Why?
| | Multimodal Imaging | 2 | 2019 | 116 | 0.130 |
Why?
| | Treatment Outcome | 8 | 2014 | 10821 | 0.130 |
Why?
| | Young Adult | 6 | 2015 | 13243 | 0.130 |
Why?
| | Cognition | 1 | 2024 | 1192 | 0.130 |
Why?
| | Leigh Disease | 2 | 2013 | 21 | 0.130 |
Why?
| | Aged | 4 | 2024 | 23798 | 0.130 |
Why?
| | Stomach | 1 | 1996 | 110 | 0.130 |
Why?
| | Intracranial Thrombosis | 1 | 2016 | 17 | 0.130 |
Why?
| | Brain Infarction | 1 | 2016 | 23 | 0.130 |
Why?
| | Cerebral Veins | 1 | 2016 | 16 | 0.120 |
Why?
| | Vascular Malformations | 1 | 2016 | 52 | 0.120 |
Why?
| | Supratentorial Neoplasms | 1 | 2015 | 17 | 0.120 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2015 | 9 | 0.120 |
Why?
| | Contrast Media | 3 | 2019 | 462 | 0.120 |
Why?
| | DNA Mutational Analysis | 2 | 2014 | 401 | 0.120 |
Why?
| | Cerebral Infarction | 1 | 2015 | 43 | 0.120 |
Why?
| | Portal Vein | 1 | 2016 | 120 | 0.120 |
Why?
| | Adrenal Gland Neoplasms | 1 | 1996 | 89 | 0.120 |
Why?
| | Delivery of Health Care | 1 | 2023 | 948 | 0.120 |
Why?
| | Temporal Lobe | 1 | 2015 | 91 | 0.120 |
Why?
| | Neurosurgical Procedures | 1 | 2017 | 199 | 0.120 |
Why?
| | Fibrin Fibrinogen Degradation Products | 2 | 2012 | 84 | 0.120 |
Why?
| | Abdominal Pain | 2 | 2011 | 146 | 0.120 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.120 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.110 |
Why?
| | Aged, 80 and over | 2 | 2024 | 7593 | 0.110 |
Why?
| | Carotid Stenosis | 1 | 2015 | 91 | 0.110 |
Why?
| | Spasm | 1 | 2013 | 20 | 0.110 |
Why?
| | Metal Metabolism, Inborn Errors | 1 | 2012 | 5 | 0.100 |
Why?
| | Cerebral Arterial Diseases | 1 | 2012 | 49 | 0.100 |
Why?
| | Alzheimer Disease | 1 | 2019 | 559 | 0.100 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 2012 | 11 | 0.100 |
Why?
| | Pons | 1 | 2012 | 27 | 0.100 |
Why?
| | DNA, Mitochondrial | 1 | 2013 | 201 | 0.100 |
Why?
| | Accidents | 1 | 2012 | 39 | 0.090 |
Why?
| | Athletic Injuries | 2 | 2016 | 525 | 0.090 |
Why?
| | Splenomegaly | 1 | 2011 | 15 | 0.090 |
Why?
| | Craniotomy | 1 | 2012 | 78 | 0.090 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2012 | 153 | 0.090 |
Why?
| | Hemoglobin SC Disease | 1 | 2011 | 13 | 0.090 |
Why?
| | Necrosis | 3 | 2019 | 244 | 0.090 |
Why?
| | Decompression, Surgical | 1 | 2012 | 100 | 0.090 |
Why?
| | Blood Coagulation Disorders | 1 | 2012 | 173 | 0.090 |
Why?
| | Succinate-CoA Ligases | 1 | 2010 | 4 | 0.090 |
Why?
| | Brain Diseases, Metabolic | 1 | 2010 | 8 | 0.090 |
Why?
| | Anticoagulants | 1 | 2015 | 665 | 0.080 |
Why?
| | Liver Diseases | 2 | 2010 | 313 | 0.080 |
Why?
| | Scoliosis | 1 | 2013 | 216 | 0.080 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2010 | 92 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 619 | 0.080 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 275 | 0.080 |
Why?
| | Recurrence | 3 | 2022 | 1060 | 0.080 |
Why?
| | Mitochondrial Diseases | 1 | 2010 | 92 | 0.080 |
Why?
| | Incidental Findings | 1 | 2010 | 87 | 0.080 |
Why?
| | Thrombophilia | 1 | 2009 | 85 | 0.080 |
Why?
| | Lymphoproliferative Disorders | 1 | 2009 | 55 | 0.080 |
Why?
| | Optic Neuritis | 1 | 2009 | 41 | 0.080 |
Why?
| | Facial Bones | 1 | 2009 | 30 | 0.080 |
Why?
| | Facial Injuries | 1 | 2009 | 21 | 0.080 |
Why?
| | Autopsy | 2 | 2016 | 94 | 0.080 |
Why?
| | Cerebellar Neoplasms | 1 | 2010 | 155 | 0.070 |
Why?
| | Liver | 2 | 2016 | 1940 | 0.070 |
Why?
| | Chromosomes, Human, Y | 1 | 2008 | 24 | 0.070 |
Why?
| | Diabetes, Gestational | 1 | 2012 | 316 | 0.070 |
Why?
| | Medulloblastoma | 1 | 2010 | 196 | 0.070 |
Why?
| | Prenatal Diagnosis | 1 | 2010 | 202 | 0.070 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2009 | 99 | 0.070 |
Why?
| | Chromosomes, Human, X | 1 | 2008 | 75 | 0.070 |
Why?
| | Biopsy | 2 | 2010 | 1132 | 0.070 |
Why?
| | Meningomyelocele | 1 | 2008 | 59 | 0.070 |
Why?
| | Sex Chromosome Aberrations | 1 | 2008 | 67 | 0.070 |
Why?
| | Craniopharyngioma | 1 | 2009 | 74 | 0.070 |
Why?
| | Lung Diseases | 1 | 2014 | 768 | 0.070 |
Why?
| | Aneuploidy | 1 | 2008 | 93 | 0.070 |
Why?
| | Middle Aged | 4 | 2024 | 33355 | 0.070 |
Why?
| | Ultrasonography, Doppler | 1 | 2008 | 123 | 0.070 |
Why?
| | Obesity | 2 | 2012 | 2974 | 0.070 |
Why?
| | Glioblastoma | 1 | 2010 | 344 | 0.070 |
Why?
| | Glucose Tolerance Test | 1 | 2008 | 361 | 0.060 |
Why?
| | Brain Injuries | 1 | 2012 | 493 | 0.060 |
Why?
| | Abnormalities, Multiple | 1 | 2008 | 189 | 0.060 |
Why?
| | Adult | 8 | 2019 | 37821 | 0.060 |
Why?
| | Vascular Diseases | 1 | 2009 | 244 | 0.060 |
Why?
| | Carotid Artery Thrombosis | 1 | 2005 | 7 | 0.060 |
Why?
| | Brain Ischemia | 1 | 2009 | 341 | 0.060 |
Why?
| | Mucormycosis | 1 | 2005 | 22 | 0.060 |
Why?
| | Osteoporosis | 1 | 2008 | 242 | 0.060 |
Why?
| | Developmental Disabilities | 1 | 2008 | 266 | 0.060 |
Why?
| | Bone Density | 1 | 2008 | 486 | 0.060 |
Why?
| | Meninges | 1 | 2024 | 43 | 0.060 |
Why?
| | Metabolic Syndrome | 1 | 2008 | 354 | 0.050 |
Why?
| | Follow-Up Studies | 4 | 2016 | 5139 | 0.050 |
Why?
| | Meningitis | 1 | 2024 | 79 | 0.050 |
Why?
| | Feasibility Studies | 2 | 2019 | 950 | 0.050 |
Why?
| | Meningeal Neoplasms | 1 | 2024 | 100 | 0.050 |
Why?
| | Carboplatin | 1 | 2003 | 144 | 0.050 |
Why?
| | Vincristine | 1 | 2003 | 116 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2024 | 123 | 0.050 |
Why?
| | Sinusitis | 1 | 2005 | 221 | 0.050 |
Why?
| | Hernia, Hiatal | 1 | 2003 | 35 | 0.050 |
Why?
| | Risk Factors | 5 | 2012 | 10356 | 0.050 |
Why?
| | Vertebral Artery | 1 | 2022 | 26 | 0.050 |
Why?
| | Hemangioendothelioma | 1 | 2002 | 15 | 0.050 |
Why?
| | Pilot Projects | 2 | 2019 | 1703 | 0.050 |
Why?
| | Pancreatic Neoplasms | 1 | 2010 | 943 | 0.050 |
Why?
| | Liver Transplantation | 1 | 2009 | 872 | 0.050 |
Why?
| | Ultrasonography, Prenatal | 2 | 2010 | 284 | 0.050 |
Why?
| | Colorado | 4 | 2015 | 4521 | 0.050 |
Why?
| | Spinal Cord Neoplasms | 1 | 2001 | 37 | 0.050 |
Why?
| | Neurofibromatosis 1 | 1 | 2001 | 52 | 0.040 |
Why?
| | Vitamin K Deficiency | 1 | 2000 | 9 | 0.040 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2000 | 35 | 0.040 |
Why?
| | Cross-Sectional Studies | 4 | 2019 | 5427 | 0.040 |
Why?
| | Dilatation | 1 | 2020 | 65 | 0.040 |
Why?
| | Herpes Simplex | 1 | 2000 | 93 | 0.040 |
Why?
| | Enema | 1 | 2000 | 47 | 0.040 |
Why?
| | Diseases in Twins | 1 | 2000 | 175 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 66 | 0.040 |
Why?
| | Mental Disorders | 1 | 2008 | 1083 | 0.040 |
Why?
| | Neck | 1 | 2019 | 101 | 0.040 |
Why?
| | Ependymoma | 1 | 2001 | 168 | 0.040 |
Why?
| | Carbolines | 1 | 2019 | 32 | 0.040 |
Why?
| | Spectrum Analysis | 1 | 2019 | 91 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2837 | 0.040 |
Why?
| | Thiazoles | 1 | 2019 | 123 | 0.040 |
Why?
| | Atrophy | 1 | 2019 | 184 | 0.040 |
Why?
| | Aniline Compounds | 1 | 2019 | 102 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 2039 | 0.040 |
Why?
| | Biomarkers | 1 | 2009 | 4172 | 0.040 |
Why?
| | Cohort Studies | 3 | 2016 | 5730 | 0.040 |
Why?
| | Organ Size | 1 | 2019 | 479 | 0.040 |
Why?
| | Pregnancy | 5 | 2012 | 6745 | 0.030 |
Why?
| | Gastroepiploic Artery | 1 | 2017 | 4 | 0.030 |
Why?
| | Cerebral Revascularization | 1 | 2017 | 19 | 0.030 |
Why?
| | Dexamethasone | 1 | 2019 | 377 | 0.030 |
Why?
| | Cerebral Angiography | 1 | 2017 | 109 | 0.030 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2016 | 39 | 0.030 |
Why?
| | Phenotype | 2 | 2019 | 3205 | 0.030 |
Why?
| | Acidosis, Lactic | 1 | 2016 | 46 | 0.030 |
Why?
| | Congenital Abnormalities | 1 | 1996 | 88 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 581 | 0.030 |
Why?
| | Florida | 1 | 2015 | 101 | 0.030 |
Why?
| | Intellectual Disability | 1 | 2017 | 165 | 0.030 |
Why?
| | Endpoint Determination | 1 | 2015 | 77 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2019 | 599 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2015 | 288 | 0.030 |
Why?
| | Observer Variation | 1 | 2015 | 347 | 0.030 |
Why?
| | Combined Modality Therapy | 2 | 2009 | 1241 | 0.030 |
Why?
| | Hemorrhage | 2 | 2015 | 723 | 0.030 |
Why?
| | Quality Assurance, Health Care | 1 | 2015 | 324 | 0.030 |
Why?
| | Molybdoferredoxin | 1 | 2012 | 12 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 339 | 0.020 |
Why?
| | Erythroblastosis, Fetal | 1 | 1972 | 3 | 0.020 |
Why?
| | Persistent Vegetative State | 1 | 2012 | 3 | 0.020 |
Why?
| | Pedigree | 1 | 2013 | 514 | 0.020 |
Why?
| | Time Factors | 2 | 2015 | 6817 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2857 | 0.020 |
Why?
| | Glasgow Coma Scale | 1 | 2012 | 182 | 0.020 |
Why?
| | Splenectomy | 1 | 2011 | 62 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3546 | 0.020 |
Why?
| | Karyotyping | 1 | 2010 | 107 | 0.020 |
Why?
| | Accidents, Traffic | 1 | 2012 | 189 | 0.020 |
Why?
| | Anemia | 1 | 1972 | 171 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2010 | 191 | 0.020 |
Why?
| | Rare Diseases | 1 | 2010 | 101 | 0.020 |
Why?
| | Optic Nerve | 1 | 2009 | 64 | 0.020 |
Why?
| | Factor VIII | 1 | 2009 | 99 | 0.020 |
Why?
| | Research Design | 1 | 2015 | 1116 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2005 | 3708 | 0.020 |
Why?
| | Fractures, Spontaneous | 1 | 2008 | 15 | 0.020 |
Why?
| | Body Composition | 1 | 2012 | 668 | 0.020 |
Why?
| | Wheelchairs | 1 | 2008 | 16 | 0.020 |
Why?
| | Calcium, Dietary | 1 | 2008 | 57 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 765 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2008 | 113 | 0.020 |
Why?
| | Cesarean Section | 1 | 2010 | 187 | 0.020 |
Why?
| | Fetal Diseases | 1 | 2010 | 172 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2010 | 328 | 0.020 |
Why?
| | Mobility Limitation | 1 | 2008 | 61 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 522 | 0.020 |
Why?
| | Gestational Age | 2 | 2010 | 903 | 0.020 |
Why?
| | Adiposity | 1 | 2012 | 517 | 0.020 |
Why?
| | Recovery of Function | 1 | 2012 | 662 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 252 | 0.020 |
Why?
| | Pancreatectomy | 1 | 2010 | 252 | 0.020 |
Why?
| | Prenatal Care | 1 | 2010 | 288 | 0.020 |
Why?
| | Bleomycin | 1 | 2009 | 247 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 359 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2009 | 411 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2008 | 205 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 2180 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2010 | 2146 | 0.020 |
Why?
| | Mucor | 1 | 2005 | 7 | 0.020 |
Why?
| | Telencephalon | 1 | 2005 | 16 | 0.020 |
Why?
| | Cavernous Sinus | 1 | 2005 | 19 | 0.020 |
Why?
| | Survival Rate | 1 | 2010 | 1980 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2010 | 2901 | 0.020 |
Why?
| | Triglycerides | 1 | 2008 | 525 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1740 | 0.020 |
Why?
| | Orbit | 1 | 2005 | 70 | 0.010 |
Why?
| | Paranasal Sinuses | 1 | 2005 | 80 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2010 | 1402 | 0.010 |
Why?
| | Prospective Studies | 2 | 2009 | 7598 | 0.010 |
Why?
| | Incidence | 1 | 2009 | 2792 | 0.010 |
Why?
| | Cleft Lip | 1 | 2003 | 49 | 0.010 |
Why?
| | Cleft Palate | 1 | 2003 | 66 | 0.010 |
Why?
| | United States | 1 | 2019 | 14696 | 0.010 |
Why?
| | Estrogen Receptor Modulators | 1 | 2001 | 17 | 0.010 |
Why?
| | Laminectomy | 1 | 2001 | 31 | 0.010 |
Why?
| | Etoposide | 1 | 2001 | 157 | 0.010 |
Why?
| | Blood Pressure | 1 | 2008 | 1776 | 0.010 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2001 | 218 | 0.010 |
Why?
| | Tamoxifen | 1 | 2001 | 202 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3439 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2001 | 392 | 0.010 |
Why?
| | Low Back Pain | 1 | 2001 | 106 | 0.010 |
Why?
| | Body Mass Index | 1 | 2008 | 2369 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1999 | 177 | 0.010 |
Why?
| | Blood Glucose | 1 | 2008 | 2183 | 0.010 |
Why?
| | Appendicitis | 1 | 1999 | 130 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 1008 | 0.010 |
Why?
| | Parathyroid Glands | 1 | 1975 | 10 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2001 | 1060 | 0.010 |
Why?
| | Infant, Newborn, Diseases | 1 | 1975 | 113 | 0.010 |
Why?
| | Pregnancy in Diabetics | 1 | 1975 | 123 | 0.010 |
Why?
| | Kidney Cortex Necrosis | 1 | 1972 | 1 | 0.010 |
Why?
| | Splenic Rupture | 1 | 1972 | 5 | 0.010 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 1972 | 16 | 0.010 |
Why?
| | Hemoperitoneum | 1 | 1972 | 12 | 0.010 |
Why?
| | Brain Edema | 1 | 1972 | 61 | 0.010 |
Why?
| | Pulmonary Edema | 1 | 1972 | 106 | 0.010 |
Why?
| | Pancreatic Diseases | 1 | 1972 | 72 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1972 | 112 | 0.010 |
Why?
| | Spleen | 1 | 1972 | 516 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 1972 | 405 | 0.000 |
Why?
| | Emergency Service, Hospital | 1 | 1999 | 2054 | 0.000 |
Why?
| | Hypocalcemia | 1 | 1975 | 27 | 0.000 |
Why?
| | Umbilical Cord | 1 | 1975 | 85 | 0.000 |
Why?
| | Blood | 1 | 1975 | 106 | 0.000 |
Why?
| | Phosphorus | 1 | 1975 | 97 | 0.000 |
Why?
| | Magnesium | 1 | 1975 | 159 | 0.000 |
Why?
| | Parathyroid Hormone | 1 | 1975 | 108 | 0.000 |
Why?
| | Phosphates | 1 | 1975 | 184 | 0.000 |
Why?
| | Calcium | 1 | 1975 | 1233 | 0.000 |
Why?
|
|
Fenton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|